Skip to main content
. 2023 Jan 23;12(3):e024792. doi: 10.1161/JAHA.121.024792

Table 5.

Baseline and Follow‐Up Echocardiogram in 667 Patients With HCM

Variable Baseline Follow‐up P value
LVEDD, mm 47.9±4.7 48.4±4.9 0.007
LVESD, mm 30.3±4.4 31.0±4.8 <0.001
LV maximal thickness, mm 18.4±3.9 19.3±4.0 <0.001
IVS thickness, mm 14.1±4.4 14.5±4.6 <0.001
PW thickness, mm 10.7±2.0 10.6±1.8 0.199
LVEF, % 69.2±8.1 68.1±7.7 0.001
LA volume index, mL/m2 36.7±14.8 43.7±19.6 <0.001
E velocity, m/s 0.63±0.2 0.66±0.2 <0.001
E/e' 14.7±6.0 15.6±6.3 <0.001
RVSP, mm Hg 28.1±7.7 29.3±9.3 0.002
MV abnormalities, n (%)
MR 150 (22.5) 157 (23.5) 0.649
Mild 128 (19.2) 129 (19.3)
Moderate 19 (2.8) 22 (3.3)
Severe 3 (0.4) 6 (0.9)
MR progression 67 (10.0)
MR regression 53 (7.9)
MS 10 (1.5) 29 (4.3) 0.002
MS progression 19 (2.8)
MAC 91 (13.6) 132 (19.8) 0.003
MAC progression 52 (7.8)
SAM 89 (13.3) 91 (13.6) 0.893
MV prolapse 16 (2.4) 18 (2.7) 0.728

Data are given as mean±SD, unless otherwise indicated. E indicates mitral inflow early diastolic filling; E/e', ratio of early diastolic mitral inflow velocity/early diastolic mitral annular tissue velocity; HCM, hypertrophic cardiomyopathy; IVS, interventricular septum; LA, left atrial; LV, left ventricular; LVEDD, LV end‐diastolic dimension; LVEF, LV ejection fraction; LVESD, LV end‐systolic dimension; MAC, mitral annular calcification; MR, mitral regurgitation; MS, mitral stenosis; MV, mitral valve; PW posterior wall; RVSP, right ventricular systolic pressure; and SAM, systolic anterior motion.